Rahul Verma, MD
Gastroenterology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 4
Offices
4 locations · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Verma’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A75754 · Current
Licensed to practise in California · since 2001 · expires 2027-04-30 · Medical College of Georgia.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Waverley Surgery Center, LPAmbulatory Surgery Center · Palo Alto, CA3.59% owner since 2020 · accredited by AAAHCAccreditation Renewed4 inspections, 3 with deficiencies · last 2024-04-25
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$104,401
Medicare paid this office $104,401 for 366 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 102 | $23,984 | $231 |
| Return visit (30+ min) | 118 | $19,627 | $112 |
| Biopsy of large bowel using a flexible endoscope | 151 | $14,282 | $94 |
| Long return visit (40+ min) | 56 | $12,071 | $168 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 107 | $8,381 | $74 |
See all 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 102 | $23,984 | $231 |
| Return visit (30+ min) | 118 | $19,627 | $112 |
| Biopsy of large bowel using a flexible endoscope | 151 | $14,282 | $94 |
| Long return visit (40+ min) | 56 | $12,071 | $168 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 107 | $8,381 | $74 |
| New patient visit (45+ min) | 50 | $6,677 | $134 |
| Short return visit (20+ min) | 41 | $4,150 | $77 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 157 | $3,282 | $14 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,273 | $205 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 14 | $1,651 | $118 |
| Injection beneath lining of large bowel using a flexible endoscope | 46 | $692 | $15 |
Procedures Medicare counted
| Colonoscopy | 93 | More than 78% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 104 | More than 78% of doctors who do this |
Who their Medicare patients are
366 Original Medicare patients in 2024. Average age 75 · Women 51% · Also on Medicaid 7% · Health risk score 0.94. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 57% · Coronary heart disease 28% · Diabetes 20% · Cancer 20% · Atrial fibrillation 14% · Chronic kidney disease 13% · Depression 12% · Heart failure 8% · COPD 7% · Dementia 3% · Stroke 3%.
The office billed $1,232,192, Medicare allowed $133,931 and paid $104,401; for 1,080 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 366 | 1,080 | 75 | 0.94 | $1,232,192 | $104,401 |
| 2023 | 374 | 886 | 74 | 0.96 | $1,225,350 | $102,942 |
| 2022 | 318 | 715 | 75 | 0.93 | $915,916 | $84,829 |
| 2021 | 298 | 639 | 74 | 1.01 | $781,249 | $80,545 |
| 2020 | 294 | 607 | 74 | 0.91 | $556,815 | $57,562 |
| 2019 | 346 | 881 | 73 | 0.90 | $832,799 | $79,694 |
| 2018 | 323 | 923 | 73 | 0.95 | $799,799 | $78,059 |
| 2017 | 313 | 880 | 74 | 1.01 | $737,670 | $77,510 |
| 2016 | 342 | 628 | 73 | 0.87 | $681,678 | $82,808 |
| 2015 | 344 | 621 | 74 | 0.97 | $670,917 | $92,409 |
| 2014 | 358 | 639 | 74 | 0.88 | $687,493 | $89,077 |
| 2013 | 314 | 645 | 73 | 1.19 | $581,088 | $84,210 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 112 | $25,449 | $221 |
| Return visit (30+ min) | 137 | $20,535 | $106 |
| Biopsy of large bowel using a flexible endoscope | 172 | $14,504 | $82 |
| Long return visit (40+ min) | 57 | $11,782 | $166 |
| New patient visit (45+ min) | 59 | $7,870 | $133 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 95 | $7,632 | $73 |
| Short return visit (20+ min) | 46 | $4,284 | $78 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,370 | $198 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 16 | $1,727 | $102 |
| Injection beneath lining of large bowel using a flexible endoscope | 36 | $854 | $24 |
2022: 10 services
| Return visit (30+ min) | 126 | $19,188 | $112 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 76 | $16,611 | $219 |
| Biopsy of large bowel using a flexible endoscope | 139 | $13,344 | $95 |
| New patient visit (45+ min) | 63 | $8,791 | $140 |
| Long return visit (40+ min) | 42 | $8,040 | $161 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 78 | $6,738 | $79 |
| Short return visit (20+ min) | 28 | $2,353 | $81 |
| New patient visit (30+ min) | 16 | $1,661 | $104 |
| Injection beneath lining of large bowel using a flexible endoscope | 26 | $996 | $38 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 11 | $985 | $90 |
2021: 8 services
| Return visit (30+ min) | 120 | $17,833 | $118 |
| Biopsy of large bowel using a flexible endoscope | 114 | $12,533 | $108 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 52 | $11,705 | $221 |
| New patient visit (45+ min) | 67 | $9,599 | $143 |
| Long return visit (40+ min) | 36 | $7,199 | $167 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 68 | $5,022 | $73 |
| Short return visit (20+ min) | 42 | $4,919 | $89 |
| Injection beneath lining of large bowel using a flexible endoscope | 21 | $279 | $13 |
2020: 11 services
| Return visit (30+ min) | 110 | $13,719 | $97 |
| Biopsy of large bowel using a flexible endoscope | 97 | $11,328 | $117 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 44 | $10,282 | $234 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 45 | $4,647 | $95 |
| New patient visit (45+ min) | 28 | $4,110 | $147 |
| Short return visit (20+ min) | 35 | $2,425 | $66 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $2,001 | $105 |
| Long return visit (40+ min) | 13 | $1,777 | $127 |
| New patient visit (30+ min) | 12 | $1,039 | $87 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 98 | $490 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 25 | $371 | $15 |
2019: 10 services
| Biopsy of large bowel using a flexible endoscope | 176 | $20,929 | $119 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 78 | $18,200 | $233 |
| Return visit (30+ min) | 100 | $12,385 | $95 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 66 | $5,469 | $78 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,422 | $201 |
| New patient visit (45+ min) | 22 | $3,382 | $154 |
| Short return visit (20+ min) | 33 | $2,684 | $67 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 215 | $1,067 | $5 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $971 | $81 |
| Injection beneath lining of large bowel using a flexible endoscope | 35 | $530 | $15 |
2018: 13 services
| Biopsy of large bowel using a flexible endoscope | 169 | $20,583 | $120 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 66 | $15,309 | $232 |
| Return visit (30+ min) | 69 | $8,305 | $90 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 90 | $6,542 | $67 |
| New patient visit (45+ min) | 24 | $3,486 | $145 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $2,791 | $186 |
| Long return visit (40+ min) | 19 | $2,561 | $128 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,528 | $96 |
| Short return visit (20+ min) | 17 | $1,303 | $69 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,076 | $90 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 82 | $1,015 | $11 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 179 | $889 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 26 | $395 | $15 |
2017: 13 services
| Biopsy of large bowel using a flexible endoscope | 144 | $19,998 | $134 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 42 | $9,763 | $232 |
| Return visit (30+ min) | 79 | $9,605 | $91 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 93 | $8,536 | $84 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $5,455 | $188 |
| Long return visit (40+ min) | 18 | $2,306 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,733 | $91 |
| New patient visit (45+ min) | 13 | $1,394 | $107 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 99 | $1,174 | $10 |
| Injection beneath lining of large bowel using a flexible endoscope | 26 | $1,069 | $41 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $955 | $80 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 123 | $536 | $4 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $396 | $10 |
2016: 11 services
| Biopsy of large bowel using a flexible endoscope | 130 | $18,240 | $139 |
| Return visit (30+ min) | 88 | $10,188 | $94 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 39 | $9,469 | $231 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 86 | $6,713 | $74 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $5,009 | $186 |
| New patient visit (45+ min) | 30 | $4,073 | $136 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,179 | $136 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,773 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,204 | $93 |
| Short return visit (20+ min) | 11 | $680 | $62 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $393 | $28 |
2015: 13 services
| Biopsy of large bowel using a flexible endoscope | 134 | $23,126 | $171 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 46 | $12,872 | $274 |
| Return visit (30+ min) | 64 | $7,789 | $97 |
| New patient visit (45+ min) | 46 | $7,359 | $160 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 60 | $7,061 | $97 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $3,241 | $232 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $3,220 | $215 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,784 | $232 |
| New patient visit (30+ min) | 25 | $2,653 | $106 |
| Short return visit (20+ min) | 28 | $2,195 | $65 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,914 | $101 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,035 | $86 |
| Injection beneath lining of large bowel using a flexible endoscope | 22 | $597 | $27 |
2014: 13 services
| Biopsy of large bowel using a flexible endoscope | 154 | $28,536 | $184 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 32 | $8,734 | $273 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | $6,071 | $76 |
| Return visit (30+ min) | 52 | $5,964 | $98 |
| Short return visit (20+ min) | 52 | $4,271 | $62 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $4,116 | $187 |
| New patient visit (30+ min) | 39 | $3,623 | $93 |
| New patient visit (45+ min) | 22 | $3,346 | $152 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,322 | $211 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,858 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,833 | $92 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,773 | $161 |
| Injection beneath lining of large bowel using a flexible endoscope | 15 | $394 | $26 |
2013: 12 services
| Biopsy of large bowel using a flexible endoscope | 101 | $18,328 | $181 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 32 | $8,711 | $272 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 69 | $6,839 | $96 |
| Short return visit (20+ min) | 74 | $6,308 | $58 |
| Return visit (30+ min) | 40 | $5,137 | $92 |
| New patient visit (30+ min) | 44 | $4,317 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $3,413 | $88 |
| New patient visit (45+ min) | 21 | $3,077 | $147 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $2,313 | $154 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,216 | $87 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,185 | $91 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $345 | $27 |
Drugs they prescribed that Part D paid
$208,172
Pharmacies billed $208,172 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 976) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
746 generic and 230 brand-name prescriptions · $208,172 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 88 | $69,535 | $790 |
| Creon | 17 | $64,857 | $3,815 |
| Trulance | 17 | $11,553 | $680 |
| Sod Sulf-Potass Sulf-Mag Sulf | 151 | $9,366 | $62 |
| Pantoprazole | 316 | $4,613 | $15 |
See all 13 drugs
| Linzess | 88 | $69,535 | $790 |
| Creon | 17 | $64,857 | $3,815 |
| Trulance | 17 | $11,553 | $680 |
| Sod Sulf-Potass Sulf-Mag Sulf | 151 | $9,366 | $62 |
| Pantoprazole | 316 | $4,613 | $15 |
| Sutab | 13 | $2,137 | $164 |
| Clenpiq | 11 | $1,889 | $172 |
| Famotidine | 97 | $1,363 | $14 |
| Sucralfate | 16 | $1,311 | $82 |
| Omeprazole | 66 | $1,070 | $16 |
| Esomeprazole Magnesium | 22 | $1,037 | $47 |
| Amitriptyline | 28 | $359 | $13 |
| Dicyclomine | 20 | $289 | $14 |
Year by year
| 2024 | 976 | 319 | 0% (0) | 24% | $208,172 |
| 2023 | 903 | 297 | None | 23% | $121,621 |
| 2022 | 850 | 275 | 0% (0) | 34% | $139,329 |
| 2021 | 714 | 254 | 0% (0) | 33% | $117,285 |
| 2020 | 819 | 276 | 0% (0) | 30% | $152,791 |
| 2019 | 1,088 | 375 | 0% (0) | 36% | $199,586 |
| 2018 | 1,009 | 308 | 0% (0) | 31% | $280,870 |
| 2017 | 978 | 281 | None | 32% | $214,671 |
| 2016 | 954 | 289 | None | 34% | $311,326 |
| 2015 | 1,007 | 295 | 0% (0) | None | $209,666 |
| 2014 | 821 | 262 | None | 39% | $140,769 |
| 2013 | 948 | 265 | None | None | $148,553 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Linzess | 65 | $51,002 | $785 |
| Trulance | 12 | $8,191 | $683 |
| Sod Sulf-Potass Sulf-Mag Sulf | 87 | $6,745 | $78 |
| Sutab | 33 | $5,411 | $164 |
| Dexlansoprazole Dr | 12 | $4,918 | $410 |
| Pantoprazole | 293 | $4,720 | $16 |
| Lubiprostone | 13 | $3,352 | $258 |
| Clenpiq | 12 | $2,127 | $177 |
| Famotidine | 85 | $1,560 | $18 |
| Sucralfate | 26 | $1,458 | $56 |
| Suprep | 11 | $1,350 | $123 |
| Omeprazole | 65 | $1,083 | $17 |
| Budesonide Dr | 11 | $911 | $83 |
| Esomeprazole Magnesium | 19 | $749 | $39 |
| Dicyclomine | 27 | $477 | $18 |
| Amitriptyline | 37 | $465 | $13 |
| Mirtazapine | 14 | $461 | $33 |
2022: 14 drugs
| Linzess | 88 | $56,100 | $637 |
| Dexilant | 25 | $16,797 | $672 |
| Clenpiq | 65 | $10,766 | $166 |
| Suprep | 52 | $5,830 | $112 |
| Mesalamine | 14 | $5,778 | $413 |
| Esomeprazole Magnesium | 18 | $5,533 | $307 |
| Pantoprazole | 253 | $4,187 | $17 |
| Lubiprostone | 12 | $4,077 | $340 |
| Sucralfate | 24 | $1,704 | $71 |
| Omeprazole | 69 | $1,325 | $19 |
| Sod Sulf-Potass Sulf-Mag Sulf | 13 | $1,071 | $82 |
| Famotidine | 37 | $743 | $20 |
| Dicyclomine | 38 | $527 | $14 |
| Amitriptyline | 43 | $291 | $7 |
2021: 12 drugs
| Linzess | 40 | $27,207 | $680 |
| Dexilant | 34 | $21,629 | $636 |
| Suprep | 92 | $10,202 | $111 |
| Mesalamine | 14 | $6,636 | $474 |
| Clenpiq | 39 | $6,310 | $162 |
| Pantoprazole | 207 | $3,597 | $17 |
| Omeprazole | 87 | $1,501 | $17 |
| Sucralfate | 11 | $948 | $86 |
| Famotidine | 29 | $708 | $24 |
| Dicyclomine | 39 | $506 | $13 |
| Amitriptyline | 14 | $168 | $12 |
| Imipramine | 12 | $86 | $7 |
2020: 15 drugs
| Xifaxan | 12 | $31,534 | $2,628 |
| Creon | 11 | $27,976 | $2,543 |
| Mesalamine | 30 | $16,596 | $553 |
| Dexilant | 32 | $15,636 | $489 |
| Linzess | 29 | $14,265 | $492 |
| Suprep | 119 | $12,351 | $104 |
| Sucralfate | 22 | $3,452 | $157 |
| Pantoprazole | 158 | $3,157 | $20 |
| Esomeprazole Magnesium | 13 | $2,103 | $162 |
| Omeprazole | 105 | $1,447 | $14 |
| Famotidine | 58 | $1,056 | $18 |
| Dicyclomine | 37 | $764 | $21 |
| Lansoprazole | 18 | $445 | $25 |
| Nortriptyline | 41 | $341 | $8 |
| Peg 3350-Electrolyte | 19 | $330 | $17 |
2019: 19 drugs
| Xifaxan | 15 | $33,409 | $2,227 |
| Linzess | 60 | $27,544 | $459 |
| Dexilant | 56 | $25,120 | $449 |
| Suprep | 168 | $16,933 | $101 |
| Mesalamine | 27 | $16,350 | $606 |
| Carafate | 24 | $11,381 | $474 |
| Pantoprazole | 143 | $2,665 | $19 |
| Ranitidine | 95 | $2,661 | $28 |
| Entecavir | 13 | $2,095 | $161 |
| Omeprazole | 102 | $1,716 | $17 |
| Esomeprazole Magnesium | 22 | $1,068 | $49 |
| Sucralfate | 26 | $957 | $37 |
| Sulfasalazine | 12 | $762 | $63 |
| Dicyclomine | 49 | $712 | $15 |
| Peg 3350-Electrolyte | 37 | $629 | $17 |
| Gavilyte-N | 30 | $513 | $17 |
| Lansoprazole | 14 | $421 | $30 |
| Nortriptyline | 21 | $259 | $12 |
| Famotidine | 14 | $176 | $13 |
2018: 20 drugs
| Dexilant | 61 | $29,293 | $480 |
| Xifaxan | 11 | $24,276 | $2,207 |
| Linzess | 42 | $19,601 | $467 |
| Mesalamine | 24 | $16,740 | $697 |
| Carafate | 33 | $16,195 | $491 |
| Entecavir | 12 | $10,026 | $835 |
| Ranitidine | 114 | $2,593 | $23 |
| Pantoprazole | 134 | $2,483 | $19 |
| Suprep | 26 | $2,435 | $94 |
| Omeprazole | 133 | $1,877 | $14 |
| Peg 3350-Electrolyte | 84 | $1,369 | $16 |
| Gavilyte-N | 55 | $896 | $16 |
| Sulfasalazine | 12 | $827 | $69 |
| Dicyclomine | 45 | $460 | $10 |
| Lansoprazole | 13 | $407 | $31 |
| Sucralfate | 12 | $182 | $15 |
| Peg 3350-Electrolyte | 13 | $127 | $10 |
| Gavilyte-C | 11 | $119 | $11 |
| Nortriptyline | 12 | $92 | $8 |
| Warfarin | 11 | $45 | $4 |
2017: 19 drugs
| Dexilant | 65 | $25,620 | $394 |
| Xifaxan | 12 | $23,777 | $1,981 |
| Budesonide Ec | 29 | $16,421 | $566 |
| Linzess | 31 | $11,052 | $357 |
| Entecavir | 12 | $9,847 | $821 |
| Carafate | 22 | $8,789 | $399 |
| Mesalamine | 11 | $5,248 | $477 |
| Omeprazole | 174 | $2,631 | $15 |
| Ranitidine | 112 | $2,085 | $19 |
| Pantoprazole | 72 | $1,755 | $24 |
| Peg 3350-Electrolyte | 104 | $1,438 | $14 |
| Sulfasalazine | 14 | $848 | $61 |
| Lansoprazole | 23 | $797 | $35 |
| Gavilyte-N | 38 | $585 | $15 |
| Dicyclomine | 45 | $448 | $10 |
| Sucralfate | 14 | $271 | $19 |
| Levothyroxine | 11 | $205 | $19 |
| Gabapentin | 12 | $148 | $12 |
| Gavilyte-C | 12 | $123 | $10 |
2016: 17 drugs
| Xifaxan | 11 | $20,608 | $1,873 |
| Dexilant | 48 | $17,289 | $360 |
| Budesonide Ec | 16 | $12,312 | $770 |
| Entecavir | 12 | $11,325 | $944 |
| Linzess | 28 | $10,175 | $363 |
| Carafate | 34 | $8,495 | $250 |
| Amitiza | 15 | $5,916 | $394 |
| Ranitidine | 115 | $2,248 | $20 |
| Omeprazole | 144 | $2,130 | $15 |
| Peg 3350-Electrolyte | 95 | $1,453 | $15 |
| Pantoprazole | 80 | $1,071 | $13 |
| Gavilyte-N | 50 | $813 | $16 |
| Sucralfate | 15 | $379 | $25 |
| Azathioprine | 15 | $320 | $21 |
| Dicyclomine | 32 | $261 | $8 |
| Propranolol | 14 | $244 | $17 |
| Ondansetron | 15 | $152 | $10 |
2015: 23 drugs
| Budesonide Ec | 12 | $11,638 | $970 |
| Dexilant | 32 | $11,011 | $344 |
| Entecavir | 11 | $10,803 | $982 |
| Pentasa | 13 | $10,465 | $805 |
| Linzess | 20 | $8,035 | $402 |
| Carafate | 24 | $7,305 | $304 |
| Amitiza | 14 | $5,331 | $381 |
| Omeprazole | 165 | $2,034 | $12 |
| Peg 3350-Electrolyte | 117 | $2,018 | $17 |
| Moviprep | 20 | $1,767 | $88 |
| Ranitidine | 96 | $1,366 | $14 |
| Pantoprazole | 115 | $1,342 | $12 |
| Ondansetron | 28 | $773 | $28 |
| Gavilyte-N | 33 | $612 | $19 |
| Sucralfate | 16 | $535 | $33 |
| Polyethylene Glycol 3350 | 12 | $447 | $37 |
| Trilyte With Flavor Packets | 12 | $232 | $19 |
| Dicyclomine | 34 | $210 | $6 |
| Propranolol | 17 | $182 | $11 |
| Metronidazole | 11 | $172 | $16 |
| Baclofen | 13 | $171 | $13 |
| Nortriptyline | 18 | $128 | $7 |
| Spironolactone | 14 | $80 | $6 |
2014: 17 drugs
| Asacol Hd | 12 | $23,162 | $1,930 |
| Budesonide Ec | 14 | $13,184 | $942 |
| Pentasa | 11 | $10,938 | $994 |
| Dexilant | 22 | $6,465 | $294 |
| Carafate | 27 | $6,022 | $223 |
| Omeprazole | 158 | $2,034 | $13 |
| Peg-3350 | 95 | $1,685 | $18 |
| Moviprep | 16 | $1,240 | $77 |
| Pantoprazole | 103 | $1,031 | $10 |
| Ranitidine | 49 | $717 | $15 |
| Gavilyte-N | 37 | $659 | $18 |
| Trilyte With Flavor Packets | 12 | $213 | $18 |
| Diphenoxylate-Atropine | 15 | $138 | $9 |
| Propranolol | 14 | $107 | $8 |
| Nortriptyline | 12 | $104 | $9 |
| Spironolactone | 13 | $89 | $7 |
| Dicyclomine | 13 | $73 | $6 |
2013: 23 drugs
| Baraclude | 22 | $22,698 | $1,032 |
| Budesonide Ec | 19 | $22,536 | $1,186 |
| Asacol Hd | 21 | $21,652 | $1,031 |
| Pentasa | 15 | $8,218 | $548 |
| Carafate | 39 | $6,697 | $172 |
| Dexilant | 29 | $5,520 | $190 |
| Omeprazole | 149 | $2,571 | $17 |
| Moviprep | 29 | $2,026 | $70 |
| Peg-3350 With Flavor Packs | 91 | $1,684 | $19 |
| Pantoprazole | 90 | $1,523 | $17 |
| Ranitidine | 73 | $927 | $13 |
| Sucralfate | 16 | $699 | $44 |
| Ondansetron | 18 | $487 | $27 |
| Sulfasalazine | 15 | $448 | $30 |
| Gavilyte-N | 24 | $400 | $17 |
| Trilyte With Flavor Packets | 20 | $379 | $19 |
| Lactulose | 12 | $287 | $24 |
| Nortriptyline | 25 | $238 | $10 |
| Diphenoxylate-Atropine | 11 | $182 | $17 |
| Dicyclomine | 15 | $127 | $8 |
| Propranolol | 16 | $98 | $6 |
| Spironolactone | 11 | $75 | $7 |
| Hydrochlorothiazide | 11 | $45 | $4 |
Money from drug and device companies
$97 in 2025
| 2025 | 3 | 3 | None | $97 |
| 2023 | 1 | 1 | None | $14 |
| 2019 | 1 | 1 | None | $126 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Braintree Laboratories | Suflave | $35 | 1 payment
|
| Pfizer | Velsipity | $31 | 1 payment
|
| Azurity Pharmaceuticals | Sutab | $31 | 1 payment
|
See all 3 published payments
| Azurity Pharmaceuticals | Meals · 2025-11-19 | Sutab | $31 |
| Braintree Laboratories | Meals · 2025-08-28 | Suflave | $35 |
| Pfizer | Education · 2025-04-14 | Velsipity | $31 |
See earlier years (2023, 2019)
2023: $14
| AbbVie | Linzess | $14 | 1 payment
|
2019: $126
| Boston Scientific | General Biliary Devices | $126 | 1 payment
|
Professional record
- NPI
- 1215002449
- Licence
- CA A75754California A75754: Current · expires 2027-04-30
- Trained
- Medical College of Georgia School of Medicine, 1995
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-11-22
- NPI last updated
- 2024-04-17
- NPI record certified
- 2024-04-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301 · 301 Industrial Rd, San Carlos, CA, 94070